#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14366	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2092	675.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1403	1403	C	806	C	781	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14366	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2092	675.1	0	HET	.	.	.	C207T	.	207	207	C	426	426	C	808	C,T	602,161	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27000	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3565	748.3	0	.	n	.	0	T695C	SNP	695	695	T	1006	1006	C	833	C,T	798,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27000	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3565	748.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2282	2282	C	840	C	806	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27000	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3565	748.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2356	2356	A	791	A	766	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27000	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3565	748.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2908	2908	C	831	C	804	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1946	folP	855	855	100.0	folP.l15.c4.ctg.1	1556	123.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1146	1148	AGC	193;194;194	A;G;C	188;189;189	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5406	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	156.9	1	SNP	p	S91F	1	.	.	271	273	TTC	623	625	TTC	190;188;188	T;T;C	184;181;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5406	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	156.9	1	SNP	p	G95N	0	.	.	283	285	GGC	635	637	GGC	189;190;188	G;G,A;C	183;183,1;181	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5406	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	156.9	1	SNP	p	D95G	1	.	.	283	285	GGC	635	637	GGC	189;190;188	G;G,A;C	183;183,1;181	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1660	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1254	130.3	1	SNP	p	G45D	0	.	.	133	135	GGC	392	394	GGC	196;193;192	G;G;C,G	193;188;185,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	852	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1007	83.3	0	.	n	.	0	A197.	DEL	197	197	A	656	656	A	175	A	168	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4456	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	151.0	1	SNP	p	D86N	0	.	.	256	258	GAC	529	531	GAC	173;173;174	G;A;C	169;165;169	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4456	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	151.0	1	SNP	p	R87I	0	.	.	259	261	CGT	532	534	CGT	173;173;172	C;G;T	169;169;163	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4456	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	151.0	1	SNP	p	R87W	0	.	.	259	261	CGT	532	534	CGT	173;173;172	C;G;T	169;169;163	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4456	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	151.0	1	SNP	p	S87R	1	.	.	259	261	CGT	532	534	CGT	173;173;172	C;G;T	169;169;163	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4456	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	151.0	1	SNP	p	S88P	0	.	.	262	264	TCC	535	537	TCC	171;169;171	T;C;C	166;166;167	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3922	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2758	140.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1618	1620	GGC	213;208;210	G;G;C	204;198;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1182	1184	GCC	240;241;242	G,C;C,T;C	230,1;230,1;226	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1185	1187	ATG	243;239;240	A;T;G	232;228;226	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1197	1199	ACC	241;242;237	A;C;C	226;232;229	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1197	1199	ACC	241;242;237	A;C;C	226;232;229	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1698	1700	ACC	197;197;198	A,G;C;C,G	180,1;189;187,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1752	1754	GCG	185;183;181	G;C;G,A	180;178;173,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1752	1754	GCG	185;183;181	G;C;G,A	180;178;173,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1875	1877	GGT	154;151;150	G;G;T	145;141;140	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1884	1886	AGC	143;141;140	A;G;C,G	133;134;132,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3948	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2365	165.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1902	1904	CCG	116;115;120	C,G;C,G;G	98,4;97,1;93	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5560	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3012	181.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	213;214;213	C;C;G	193;200;200	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2230	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1783	123.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	602	602	C	136	C	132	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2498	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1551	158.4	0	.	p	.	0	E209_G210del	DEL	625	625	G	935	935	G	187	G	178	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2498	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1551	158.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	951	953	GGT	179;177;179	G,A;G;T	175,1;174;173	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2498	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1551	158.4	1	SNP	p	G120K	1	.	.	358	360	AAG	669	671	AAG	211;213;210	A;A;G,A	201;208;200,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2498	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1551	158.4	1	SNP	p	N121D	0	.	.	361	363	AAC	672	674	AAC	212;210;211	A;A,T;C,A	205;202,1;201,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2498	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1551	158.4	1	SNP	p	A121N	1	.	.	361	363	AAC	672	674	AAC	212;210;211	A;A,T;C,A	205;202,1;201,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9394	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4933	187.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1030	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	970	104.9	1	SNP	p	V57M	1	.	.	169	171	ATG	484	486	ATG	209;211;210	A,G;T;G	202,1;204;203	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
